Primary Site >> Biliary tract Cancer
Gene >> TGFB1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. PMID: 7705781 Ref: [Hepatic neoductules]. PMID: 8600693 |
Ref: [Effect of recombinant human basic fibroblast growth factor (bFGF) on the growth of human tumor cell lines]. PMID: 9183641 |
Ref: Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. PMID: 10468286 |
Ref: Disrupted transforming growth factor-beta signaling and deregulated growth in human biliary tract cancer cells. PMID: 10842191 Ref: Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. PMID: 10869285 Ref: Abnormal distribution of collagen type IV in extrahepatic bile duct carcinoma. PMID: 11107064 |
Ref: Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer. PMID: 12579267 Ref: Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. PMID: 12615726 Ref: Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma. PMID: 12917766 Ref: Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas. PMID: 14696408 |
Ref: Influence of the site of human gallbladder xenograft (Mz-ChA-1) on angiogenesis at the distant site. PMID: 15010876 |
Ref: Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1. PMID: 15696189 Ref: [Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance]. PMID: 16083599 |
Ref: Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma. PMID: 16792547 Ref: Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth. PMID: 17072955 |
Ref: Restoration of RUNX3 enhances transforming growth factor-beta-dependent p21 expression in a biliary tract cancer cell line. PMID: 17470130 |
Ref: Thalidomide attenuates tumor growth and preserves fast-twitch skeletal muscle fibers in cholangiocarcinoma rats. PMID: 18291259 Ref: Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer. PMID: 18571008 |
Ref: Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma. PMID: 20489148 |
Ref: E/N-cadherin switch mediates cancer progression via TGF-beta-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. PMID: 22068819 |
Ref: Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss. PMID: 21898503 Ref: A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver. PMID: 22729936 Ref: Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. PMID: 23480772 |
Ref: Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer. PMID: 23298711 Ref: MiR-20a triggers metastasis of gallbladder carcinoma. PMID: 23665284 Ref: Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma. PMID: 23775819 Ref: Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor. PMID: 23787814 Ref: JNK inhibitor SP600125 enhances TGF-beta-induced apoptosis of RBE human cholangiocarcinoma cells in a Smad-dependent manner. PMID: 24100678 Ref: Protective Effects of Guava Pulp on Cholestatic Liver Injury. PMID: 27335829 |
Ref: NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer. PMID: 24310606 Ref: Transcriptional profiles of peripheral blood leukocytes identify patients with cholangiocarcinoma and predict outcome. PMID: 24935374 Ref: Transforming growth factor-beta1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma. PMID: 25194504 Ref: Autophagy may promote carcinoma cell invasion and correlate with poor prognosis in cholangiocarcinoma. PMID: 25197362 |
Ref: Connective tissue growth factor and integrin alphavbeta6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice. PMID: 25203810 Ref: Downregulation of FOXP3 inhibits invasion and immune escape in cholangiocarcinoma. PMID: 25623530 Ref: CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder. PMID: 26249215 Ref: Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination. PMID: 26325075 |
Ref: Integrin beta3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma. PMID: 26517522 Ref: Epithelial Transforming Growth Factor-beta Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma. PMID: 26627606 Ref: A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer. PMID: 26726879 Ref: Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition. PMID: 27073719 Ref: Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion. PMID: 27449039 |
Ref: Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma. PMID: 28178615 Ref: Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands. PMID: 28439013 Ref: Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- beta1-SMAD3-ID1 signaling pathway. PMID: 28611292 Ref: TGF-beta signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures. PMID: 28873435 Ref: Blocking ERK1/2 signaling impairs TGF-beta1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells. PMID: 28959141 |
Ref: A novel transforming growth factor beta-induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma. PMID: 29507901 Ref: CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma. PMID: 29510695 Ref: beta4 and beta6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma. PMID: 29584696 Ref: S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma. PMID: 30182496 |